MK-3475-C66
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Novartis
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Bristol-Myers Squibb
Pfizer
Seagen Inc.
Fate Therapeutics
Tianjin Medical University Cancer Institute and Hospital
Alterome Therapeutics, Inc.
Verastem, Inc.
Novartis
Revolution Medicines, Inc.
Hoffmann-La Roche
University of Chicago
Revolution Medicines, Inc.
Erasca, Inc.
Erasca, Inc.
Eastern Cooperative Oncology Group
Incyte Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)